Clinical Trial Highlights

• PARAMOUNT Trial Results
• TRILOGY ACS Outcomes
• Results from the ALTITUDE Trial
• Results of the WOEST Trial
• Results from the Aldo-DHF Trial
• FAME 2 Results
• Results from the IABP-SHOCK II Trial
• STEMI Mortality Decreases in France While Some Key Risk Factors Increase
• Results from the PURE Study
• PURE: Treatment and Control of Hypertension
• Genetic Determinants of Variability in Dabigatran Exposure
• The RE-LY AF Registry
• TRA 2°P-TIMI 50 Results
• Rivaroxaban of Benefit in STEMI: ATLAS ACS 2-TIMI 51
• Ivabradine Effect on Recurrent Hospitalization for HF
• CLARIFY: Similar 1-Year Outcomes for Men and Women with Stable CAD
• HPS2-THRIVE Results
• PRoFESS Study Results
• Outcomes from the CARDia Trial